Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) seeking approval for its COVID-19 and Influenza combination vaccine for ...

Novavax said the Food and Drug Administration has put a hold on its application for a combination shot targeting Covid and influenza and a stand-alone flu vaccine, sending shares of the company down ...

Add Yahoo as a preferred source to see more of our stories on Google. Illustration shows Moderna logo (Reuters) -Moderna said on Friday it has filed a marketing application for the review of its ...

April 21 (Reuters) - Moderna said on Tuesday the European Commission had approved its combination vaccine for the prevention ...

May 23 (Reuters) - Moderna (MRNA.O), opens new tab said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food and Drug Administration. The ...